Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

2 High-Growth Stocks to Buy in April 2022

Published 2022-04-01, 10:30 a/m
© Reuters.  2 High-Growth Stocks to Buy in April 2022
NVEI
-

Canadian growth stocks have seen a substantial pullback in 2022. While it is difficult to tell if they have hit a bottom, they have seen a decent bounce back in recent weeks.

Undoubtably, market volatility will persist into April. Consequently, dips could be a good buying opportunity, especially for investors willing to have a long-term mindset.

It is impossible to pick the bottom of a bear market. However, picking quality companies with long-term prospects for revenue, earnings, and cash flow growth has been a winning formula for patient, buy-and-hold investors.

It is a bonus if you can buy these Canadian growth stocks at a discounted price. If you are looking for some high-growth stocks to buy in April, here are two to consider.

Nuvei (TSX:NVEI): Growth and profitability ahead Nuvei (TSX:NVEI)(NASDAQ:NVEI) has had a strong recovery from lows hit in early March. Its stock is up 38% in the past month. However, at $95 per share, it still trades nearly 45% from its highs late last year.

Nuvei provides specialized payments technologies across the world. Its platform provides optionality in how merchants accept, authenticate, and manage a wide spectrum of payment formats (including cryptocurrency). Given the massive transformation in fintech, it is a great one-stop shop for merchants looking for optionality.

Last year, Nuvei nearly doubled its revenues and adjusted EBITDA. Unlike many tech peers, this company is profitable; it produces high +40% EBITDA margins and a significant amount of free cash flow. While growth will slow from 2021, it is still aiming for +30% growth in revenues and earnings.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Nuvei is not exactly cheap. It trades for 11 times sales and has an enterprise value-to-EBITDA (EV/EBITDA) ratio of 25. However, if it can sustain its long-term 30% growth targets for many years ahead, it may certainly be an attractive entry point here.

Calian Group: A Canadian growth stock at a reasonable price If you are looking for growth at a more fair value, Calian Group (TSX:CGY) is a Canadian stock to consider. Calian operates four business segments in healthcare, IT/cybersecurity, advanced technologies, and learning.

It has specialized services in nuclear safety, military simulation/training, satellite communications, advanced military equipment, cybersecurity, and threat prevention/management. Some of Calian’s largest customers are defence-related (i.e., the Canadian military, NATO, and the European Space Agency).

Given the conflict in Ukraine, many Western nations are increasing their military and security spending. Calian could be well positioned to benefit from increased defence spending.

Over the past two years, it has grown revenues by 20%. EBITDA has risen by twice that rate. Given a recent acquisition in the cybersecurity space, it believes it could hit similar growth targets in 2022.

Calian has a great balance sheet with a net cash position, so further acquisitions could be on the books. While this Canadian stock is up nearly 15% in the past month, it only trades with an EV/EBITDA ratio of 11 and a price-to-earnings ratio of 16. It also pays an attractive 1.6% dividend.

If you want a Canadian stock with lots of growth ahead but at a reasonable price, Calian is one of the best you can find today.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The post 2 High-Growth Stocks to Buy in April 2022 appeared first on The Motley Fool Canada.

Fool contributor Robin Brown owns Calian Group Ltd. and Nuvei Corporation. The Motley Fool owns and recommends Nuvei Corporation. The Motley Fool recommends Calian Group Ltd.

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.